Pfizer Gets European Commission Approval for Zirabev, an Industrial Info Market Brief
Attachment: Pfizer
The European Commission has granted approval for Pfizer's Zirabev, which is a biosimilar drug to Avastin used in cancer treatment. Pfizer has 16 operational sites in Europe.